News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
The Trump administration’s shift to narrow approval for coronavirus vaccines to only those who are at high risk for severe disease has raised concerns among Americans who came to rely on annual ...
Limiting access stops healthy adults and children living with elderly or immunocompromised family members from choosing to do ...
The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...
The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback